Nepafenac Compared to Placebo for Ocular Pain and Inflammation

Summary

The purpose of this study was to demonstrate that Nepafenac Ophthalmic Suspension, 0.1% is superior to Nepafenac Vehicle (placebo) for the prevention and treatment of ocular inflammation and pain associated with cataract surgery in Chinese subjects.

Timeline

Start

2011-07

Primary completion

2012-04

Completion

2012-04

Drugs

Indications